Dr Summers studied undergraduate medicine at the University of St Andrews and the University of Manchester, graduating in 1993 and subsequently completed higher specialist training in Medical Oncology at the Christie Hospital, Manchester between 1997 and 2004. During this period she was awarded a doctorate for research in the field of stem cell biology.

In 2004 she commenced her first post as consultant medical oncologist in the Northern Ireland Cancer Centre, Belfast, where she concentrated her efforts on establishing a medical oncology service for lung cancer patients and introducing clinical trial research.
She returned to Manchester in 2009, where she specialises in thoracic oncology, is Clinical Director for Medical Oncology at the Christie Hospital.

In addition to the clinical service, she has experience as UK chief investigator and principal investigator in commercial and academic clinical studies. She influences lung cancer research & treatment through work NHS England’s lung cancer clinical expert group (CEG) and as a clinical expert for NICE technology appraisals and was a previous member of the NIHR clinical studies group (CSG) and Chair of the LORD subgroup of the lung CSG and previously chaired the Christie Drugs and Therapeutics Committee.

Yvonne Summers

The Christie, Manchester

Topic: Standard Strategies for Advanced ALK and ROS1-Mutant NSCLC